Clinical Social Workers in Bridgeton, MO Accepting Medicare
66 Clinical Social Workers found. Showing 61 - 66
 Joan P Hapka-tracy Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3165 Mckelvey Rd, Suite 200, Bridgeton, MO 63044 Phone: 314-206-3900 Fax: 314-206-3992 |
Shelly Claywell Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12255 Depaul Dr, Suite 500, Bridgeton, MO 63044 Phone: 314-209-5180 |
Diana Gregory, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3751 Pennridge Dr Ste 119, Bridgeton, MO 63044 Phone: 314-443-7776 Fax: 949-561-4148 |
Mrs. Catherine Nagus, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12303 De Paul Dr, Bridgeton, MO 63044 Phone: 314-344-7968 |
Miss Michelle Joy Wharry, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3165 Mckelvey Rd, Suite 200, Bridgeton, MO 63044 Phone: 314-206-3900 Fax: 314-206-3992 |
 Mr. David Todd Lipson, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3165 Mckelvey Rd, Suite 200, Bridgeton, MO 63044 Phone: 314-206-3911 Fax: 314-206-3992 |
News Archive
Pediatric vaccine propels sharp drop in meningitis cases
A pediatric vaccine with University of Rochester roots has proven to be highly successful at reducing cases of bacterial meningitis across all age groups.That is the conclusion of a seven-year study, the results of which appeared today in the New England Journal of Medicine.
Human-worm connection research provides insight into brain development, diseases
"Man is but a worm" was the title of a famous caricature of Darwin's ideas in Victorian England. Now, 120 years later, a molecular analysis of mysterious marine creatures unexpectedly reveals our cousins as worms, indeed.
ImmunoCellular Therapeutics receives Notice of Allowance on ICT-69 monoclonal antibody
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.
Bone-marrow-derived MSCs can promote fracture healing
Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
› Verified 1 days ago
Counselors
Clinical Social Workers
Pharmacists
Occupational Therapists
Dentists